SCHEMBL4358423

SCHEMBL4358423

CC(C)(Cc1cccc(-c2ccc(F)cc2F)n1)OC(=O)N1CCNCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 2/20 0.40
▸ SCN9A Q15858 1/20 0.37
▸ CCNT1 O60563 2/20 0.36
▸ CCNA2 P20248 1/20 0.36
▸ CDK2 P24941 1/20 0.36
▸ CDK9 P50750 1/20 0.36
▸ CCNA1 P78396 1/20 0.36
▸ MAPK14 Q16539 1/20 0.36
▸ CNR1 P21554 3/20 0.35
▸ GPR119 Q8TDV5 1/20 0.35
▸ ALPL P05186 1/20 0.35
▸ CTSA P10619 1/20 0.35
▸ HDAC1 Q13547 1/20 0.34
▸ HDAC2 Q92769 1/20 0.34
▸ KMO O15229 1/20 0.34
▸ HRH4 Q9H3N8 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4369710 0.87 CXCR2 (0.37) FAAHCCNT1CDK9GPR119CTSA
SCHEMBL4372425 0.81 FAAH (0.40) FAAHCCNT1CCNA2CDK2CDK9
SCHEMBL4363957 0.81 P2RY12 (0.41) —
SCHEMBL4360123 0.78 FAAH (0.38) FAAHHRH4
SCHEMBL4358419 0.75 FAAH (0.42) FAAHSCN9ACCNT1CCNA2CDK2
SCHEMBL3268450 0.73 FAAH (0.60) FAAHCCNT1CCNA2CDK2CDK9
SCHEMBL30254155 0.73 ALDH1A1 (0.45) GPR119ALDH1A1
SCHEMBL29155320 0.69 SIGMAR1 (0.45) GPR119
SCHEMBL3272680 0.68 FAAH (0.53) FAAHCNR1ALDH1A1HTTCYP2C9
SCHEMBL3269713 0.67 FAAH (0.61) FAAHCCNT1CCNA2CDK2CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090163508-A1 AMIDE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163508-A1 AMIDE COMPOUND FAAH, FAAH2, NAAA FAAH 1/4885SCN9A 288/4885CCNT1 2773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback